Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Belén Garijo López
CEOBelén Garijo López
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
100.86B
Market cap100.86B
Price-Earnings ratio
17.62
Price-Earnings ratio17.62
Dividend yield
4.16%
Dividend yield4.16%
Average volume
3.52M
Average volume3.52M
High today
$41.82
High today$41.82
Low today
$40.75
Low today$40.75
Open price
$40.90
Open price$40.90
Volume
5.75M
Volume5.75M
52 Week high
$52.68
52 Week high$52.68
52 Week low
$40.75
52 Week low$40.75

SNY News

TipRanks 10h
MacroGenics to receive $24.5M milestone payment from Sanofi

MacroGenics (MGNX) announced that it will receive a $24.5M regulatory milestone payment from Sanofi (SNY) following the U.S. Food and Drug Administration’s acce...

TipRanks 17h
Sanofi Wins FDA Accelerated Approval for Tzield in Newly Diagnosed Stage 3 Type 1 Diabetes Children

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

TipRanks 17h
Sanofi appoints Paulo Fontoura as Global Head of R&D

Sanofi (SNY) announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of Research & Development Pharma, effective Se...

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

More SNY News

TipRanks 17h
Sanofi investors likely to view new R&D head as a positive, says BofA

After Sanofi (SNY) announced a new head of R&D with Paulo Fontoura replacing Houman Ashrafian, BofA analyst Sachin Jain says investors are likely to view Fontou...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.